Restoring the NHS 18 Week Pathway

The NHS 18 week Referral to Treatment standard is a cornerstone of patient-centred care. It stipulates that patients should begin non urgent consultant led treatment within 18 weeks from referral, with a legal right to do so. For many years this target has become aspirational rather than guaranteed. In October 2024, only 58 percent of patients met the 18 week deadline, while over 250,000 had waited more than a year.

What Is the 18 Week Pathway and Why Is It Controversial?

The 18 week pathway, also known as Referral to Treatment or RTT, was introduced in 2004 to improve patient experience and ensure timely access to care. A diagnosis, test or treatment should begin no later than 18 weeks after a GP referral, unless the patient chooses to wait or it is clinically appropriate to delay.

But reality has fallen far short of the promise. A decade of underinvestment, worsened by the COVID 19 pandemic and staff shortages, has seen open care pathways rise from around 4.4 million in 2020 to over 7.6 million by late 2024. Backlogs continue to grow. The standard itself remains elusive. The last time more than 90 percent of patients were treated within 18 weeks was in 2016.

This has spurred political and operational controversy. The current Labour Government has pledged to restore 92 percent RTT compliance by March 2029. But many experts warn that capacity alone will not suffice without transformative change in how care is delivered.

The 18 Week Crisis: Causes and Impacts

Several factors have contributed:

• Demand for elective care has risen consistently year on year, driven by population ageing and more complex health needs
• Industrial action across the NHS has reduced activity by up to 25 percent on strike days
• Seasonal pressures and winter surges have displaced elective services

As a result, NHS trust boards face mounting pressure to eliminate unnecessary waits beyond 18 weeks and rebuild patient confidence.

What Is Insourcing and How Can It Help?

Insourcing refers to bringing in external clinical teams to deliver care within NHS hospitals, using NHS equipment, records systems, and governance structures. This typically takes place during evenings and weekends. It differs from outsourcing, where patients are sent to private facilities outside NHS control.

Insourcing increases capacity quickly by unlocking unused clinical space and time within NHS sites. It is highly cost effective, avoids capital spending, and ensures patients are treated in familiar NHS environments. Many trusts now use insourcing NHS solutions to tackle elective care backlogs while maintaining full oversight of clinical quality.

Why Use Insourcing to Achieve the 18 Week Target?

Rapid Capacity Expansion

Elective Services’ insourced clinics allow trusts to deliver additional outpatient clinics, diagnostics and day case procedures without adding pressure to weekday rotas.

Alignment with NHS Governance

All services are consultant led and delivered in line with NHS clinical governance. Patients benefit from consistency of care and clear clinical accountability.

Focused Backlog Reduction

By targeting patients who have already waited over 18 weeks, insourcing helps trusts reduce open care pathways and move closer to national targets.

Cost Effective and Scalable

Insourcing is delivered using NHS rates and avoids the premium costs associated with outsourcing to private hospitals. It delivers excellent value for money.

How Does Insourcing Differ from Outsourcing?

Outsourcing typically involves moving patients to private hospitals. This can introduce new IT systems, separate governance processes, and a disconnect from NHS values. It may also result in higher costs and reduced continuity of care.

Insourcing, on the other hand, keeps services inside NHS premises, under NHS management, with NHS staff or approved clinical partners. Patients receive care in familiar settings, and trusts retain oversight. For RTT compliance and long term sustainability, insourcing in the UK offers a more integrated and patient friendly approach.

Elective Services: Delivering Insourcing for the 18 Week Pathway

At Elective Services, we specialise in delivering flexible, consultant led insourcing services that directly support RTT performance:

• Additional weekend and evening clinics
• Diagnostic and treatment sessions tailored to high demand specialties
• Full integration with trust RTT monitoring and reporting
• Transparent activity data and governance reporting
• Customised service models that reflect local population needs

Our model helps NHS trusts reduce RTT delays, manage referral volumes, and work towards full compliance with the 18 week standard.

Restoring the 18 Week Standard: A Pragmatic Pathway

The Labour Government has committed to achieving 92 percent RTT compliance by March 2029. To meet this goal, NHS trusts will need to both increase capacity and adopt new models of care delivery. Simply adding more appointments within existing working hours will not be enough.

Insourcing offers a transformative approach. By delivering high volume, consultant-led activity during evenings and weekends, Elective Services helps trusts clear backlogs without compromising safety or governance. Our flexible approach supports the NHS in making the 18 week promise a reality again.

Conclusion

The 18 week RTT standard remains one of the NHS’s most important measures of patient access and service quality. While recent years have seen it slip out of reach, solutions are available.

Elective Services insourcing services offer NHS trusts a proven, scalable way to expand capacity, improve RTT performance, and reduce waiting lists. If your organisation is under pressure to meet targets or deliver recovery plans, why use insourcing is no longer the question. The answer is clear: insourcing delivers fast, safe, and effective care — when and where your patients need it most.

Contact Elective Services Contact Elective Services today to learn how we can support your trust’s elective recovery and help restore the 18 week standard.